Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000933
Chunk: 73

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 73
---
 shall reimburse each Indemnified Person promptly as such expenses are incurred and are due and payable, for
any reasonable and documented legal fees or other reasonable expenses incurred by them in connection with investigating or defending any
such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this :
(i) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in
conformity with information about the Investor furnished in writing to the Company by such Indemnified Person expressly for use in connection
with the preparation of the Registration Statement, any New Registration Statement or any such amendment thereof or supplement thereto
or prospectus contained therein, if such Registration Statement, New Registration Statement or amendment thereof or supplement thereof
or prospectus contained therein was timely made available by the Company pursuant to ) or ; (ii)
with respect to any superseded prospectus, shall not inure to the benefit of any such Person from whom the Person asserting any such Claim
purchased the Registrable Securities that are the subject thereof (or to the benefit of any Person controlling such Person) if the untrue
statement or omission of material fact contained in the superseded prospectus was corrected in the revised prospectus, as then amended
or supplemented, if such revised prospectus was timely made available by the Company pursuant to or ,
and the Indemnified Person was promptly advised in writing not to use the incorrect prospectus prior to the use giving rise to a violation
and such Indemnified Person, notwithstanding such advice, used it; (iii) shall not be available to the extent such Claim is based on a
failure of the Investor to deliver or to cause to be delivered the prospectus made available by the Company, if such prospectus was timely
made available by the Company pursuant to or ; and (iv) shall not apply to amounts paid in settlement
of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably
withheld. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified
Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to .

| 7 |

b. In
connection with the Registration Statement or any New Registration Statement or prospectus, the Investor agrees to indemnify, hold harmless
and defend, to the same extent and in the same manner